This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Parra, M. Articles by Brennan, M. J. Search for Related Content PubMed PubMed Citation Articles by Parra, M. Articles by Brennan, M. J.

 Previous Article  |  Next Article 

Infection and Immunity, December 2004, p. 6799-6805, Vol. 72, No. 12
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.12.6799-6805.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

The Mycobacterial Heparin-Binding Hemagglutinin Is a Protective Antigen in the Mouse Aerosol Challenge Model of Tuberculosis

Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland,¹ Institute of Microbiology, Catholic University of the Sacred Heart, Rome, Italy,² Unite INSERM U447, Institut Pasteur de Lille, Lille Cedex, France³

Received 23 June 2004/ Returned for modification 5 August 2004/ Accepted 24 August 2004

The heparin-binding hemagglutinin (HBHA) of Mycobacterium tuberculosis is a surface-expressed adhesin that can affect binding to host cells via a unique, methylated, carboxyl-terminal, lysine-, alanine-, and proline-rich repeat region. It has been implicated in extrapulmonary dissemination of M. tuberculosis from the lung following the initial infection of the host. To assess the vaccine potential of this protein, purified preparations of HBHA were emulsified in a dimethyldioctadecylammonium bromide-monophosphoryl lipid A adjuvant and tested for the ability to reduce M. tuberculosis infection in the mouse aerosol challenge model for tuberculosis. The HBHA-containing vaccine gave a 0.7-log reduction in CFU in both mouse lungs and spleens compared to adjuvant controls 28 days following challenge. Although a notable level of serum antibody to HBHA was elicited after three immunizations and the antibodies were able to bind to the surface of M. tuberculosis, passive immunization with monoclonal antibodies directed against HBHA did not protect in the challenge model. Compared to adjuvant controls, an elevated gamma interferon response was generated by splenic and lymph node-derived T cells from immunized mice in the presence of macrophages pulsed with purified HBHA or infected with live M. tuberculosis, suggesting that the effective immunity may be cell mediated. Efforts to construct effective recombinant HBHA vaccines in fast-growing Mycobacterium smegmatis have been unsuccessful so far, which indicates that distinctive posttranslational modifications present in the HBHA protein expressed by M. tuberculosis are critical for generating effective host immune responses. The vaccine studies described here demonstrate that HBHA is a promising new vaccine candidate for tuberculosis.

Editor: J. T. Barbieri

This article has been cited by other articles:

• Esposito, C., Pethoukov, M. V., Svergun, D. I., Ruggiero, A., Pedone, C., Pedone, E., Berisio, R. (2008). Evidence for an Elongated Dimeric Structure of Heparin-Binding Hemagglutinin from Mycobacterium tuberculosis. J. Bacteriol. 190: 4749-4753 [Abstract] [Full Text]  
• Hougardy, J.-M., Place, S., Hildebrand, M., Drowart, A., Debrie, A.-S., Locht, C., Mascart, F. (2007). Regulatory T Cells Depress Immune Responses to Protective Antigens in Active Tuberculosis. Am. J. Respir. Crit. Care Med. 176: 409-416 [Abstract] [Full Text]  
• Delogu, G., Sanguinetti, M., Posteraro, B., Rocca, S., Zanetti, S., Fadda, G. (2006). The hbhA Gene of Mycobacterium tuberculosis Is Specifically Upregulated in the Lungs but Not in the Spleens of Aerogenically Infected Mice.. Infect. Immun. 74: 3006-3011 [Abstract] [Full Text]  
• Parra, M., Cadieux, N., Pickett, T., Dheenadhayalan, V., Brennan, M. J. (2006). A PE Protein Expressed by Mycobacterium avium Is an Effective T-Cell Immunogen. Infect. Immun. 74: 786-789 [Abstract] [Full Text]  
• Shin, S. J., Chang, C.-F., Chang, C.-D., McDonough, S. P., Thompson, B., Yoo, H. S., Chang, Y.-F. (2005). In Vitro Cellular Immune Responses to Recombinant Antigens of Mycobacterium avium subsp. paratuberculosis. Infect. Immun. 73: 5074-5085 [Abstract] [Full Text]